327 related articles for article (PubMed ID: 28632040)
1. Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.
Bunderson-Schelvan M; Holian A; Hamilton RF
J Toxicol Environ Health B Crit Rev; 2017; 20(4):230-248. PubMed ID: 28632040
[TBL] [Abstract][Full Text] [Related]
2. The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.
Pietroiusti A; Bergamaschi E; Campagna M; Campagnolo L; De Palma G; Iavicoli S; Leso V; Magrini A; Miragoli M; Pedata P; Palombi L; Iavicoli I
Part Fibre Toxicol; 2017 Nov; 14(1):47. PubMed ID: 29178961
[TBL] [Abstract][Full Text] [Related]
3. Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver.
Llewellyn SV; Conway GE; Zanoni I; Jørgensen AK; Shah UK; Seleci DA; Keller JG; Kim JW; Wohlleben W; Jensen KA; Costa A; Jenkins GJS; Clift MJD; Doak SH
J Nanobiotechnology; 2021 Jun; 19(1):193. PubMed ID: 34183029
[TBL] [Abstract][Full Text] [Related]
4. L-leucyl-L-leucine methyl ester does not release cysteine cathepsins to the cytosol but inactivates them in transiently permeabilized lysosomes.
Repnik U; Borg Distefano M; Speth MT; Ng MYW; Progida C; Hoflack B; Gruenberg J; Griffiths G
J Cell Sci; 2017 Sep; 130(18):3124-3140. PubMed ID: 28754686
[TBL] [Abstract][Full Text] [Related]
5. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
6. Nanotoxicity: emerging concerns regarding nanomaterial safety and occupational hard metal (WC-Co) nanoparticle exposure.
Armstead AL; Li B
Int J Nanomedicine; 2016; 11():6421-6433. PubMed ID: 27942214
[TBL] [Abstract][Full Text] [Related]
7. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
8. Ecophysiological perspectives on engineered nanomaterial toxicity in fish and crustaceans.
Callaghan NI; MacCormack TJ
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Mar; 193():30-41. PubMed ID: 28017784
[TBL] [Abstract][Full Text] [Related]
9. Phagolysosome acidification is required for silica and engineered nanoparticle-induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity.
Jessop F; Hamilton RF; Rhoderick JF; Fletcher P; Holian A
Toxicol Appl Pharmacol; 2017 Mar; 318():58-68. PubMed ID: 28126413
[TBL] [Abstract][Full Text] [Related]
10. Occupational Exposures to Engineered Nanomaterials: a Review of Workplace Exposure Assessment Methods.
McCormick S; Niang M; Dahm MM
Curr Environ Health Rep; 2021 Sep; 8(3):223-234. PubMed ID: 34101152
[TBL] [Abstract][Full Text] [Related]
11. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
Warheit DB; Borm PJ; Hennes C; Lademann J
Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
[TBL] [Abstract][Full Text] [Related]
12. Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials.
Gordon SC; Butala JH; Carter JM; Elder A; Gordon T; Gray G; Sayre PG; Schulte PA; Tsai CS; West J
Regul Toxicol Pharmacol; 2014 Apr; 68(3):305-11. PubMed ID: 24462629
[TBL] [Abstract][Full Text] [Related]
13. Surfactant Proteins A/D-CD14 on Alveolar Macrophages Is a Common Pathway Associated With Phagocytosis of Nanomaterials and Cytokine Production.
Wang Q; Wang Q; Zhao Z; Fan J; Qin L; Alexander DB; Tsuda H; Zhao D; Xu J
Front Immunol; 2021; 12():758941. PubMed ID: 34777371
[TBL] [Abstract][Full Text] [Related]
14. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation.
Campden RI; Zhang Y
Arch Biochem Biophys; 2019 Jul; 670():32-42. PubMed ID: 30807742
[TBL] [Abstract][Full Text] [Related]
15. Current state of knowledge on the health effects of engineered nanomaterials in workers: a systematic review of human studies and epidemiological investigations.
Schulte PA; Leso V; Niang M; Iavicoli I
Scand J Work Environ Health; 2019 May; 45(3):217-238. PubMed ID: 30653633
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production.
Windelborn JA; Lipton P
J Neurochem; 2008 Jul; 106(1):56-69. PubMed ID: 18363826
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review of the Routes and Forms of Exposure to Engineered Nanomaterials.
Basinas I; Jiménez AS; Galea KS; Tongeren MV; Hurley F
Ann Work Expo Health; 2018 Jul; 62(6):639-662. PubMed ID: 29931230
[TBL] [Abstract][Full Text] [Related]
18. International landscape of limits and recommendations for occupational exposure to engineered nanomaterials.
Rodríguez-Ibarra C; Déciga-Alcaraz A; Ispanixtlahuatl-Meráz O; Medina-Reyes EI; Delgado-Buenrostro NL; Chirino YI
Toxicol Lett; 2020 Apr; 322():111-119. PubMed ID: 31981686
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Human Exposure to ENMs.
Jiménez AS; van Tongeren M
Adv Exp Med Biol; 2017; 947():27-40. PubMed ID: 28168664
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal membrane permeabilization as a cell death mechanism in cancer cells.
Serrano-Puebla A; Boya P
Biochem Soc Trans; 2018 Apr; 46(2):207-215. PubMed ID: 29472365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
